Abstract
The biliary tree is exclusively supplied by the hepatic artery, so hepatic arterial insufficiency and also the damages to the hepatic arteries and their branches including peribiliary vascular plexus (PVP) give rise to various forms of ischemic biliary damages (ischemic cholangiopathies). Ischemic cholangiopathies are composed of several clinicopathological categories such as bile duct necrosis, bile leak and biloma, biliary strictures, and biliary casts. Ischemic cholangiopathies related to liver transplantation including nonanastomotic ischemic-type biliary stricture and biliary cast syndrome and also those associated with transarterial chemoembolization including bile duct necrosis and biloma are well known, though ischemic cholangiopathies also occur spontaneously and in other medical treatments. Hypoxic injuries to hepatic arterial branches including PVP and biliary epithelial cells (BECs) seem to be essential. In addition, ABH blood type and HLA antigens expressing on endothelial cells in the PVP and BECs in the large bile ducts could be targets by an immunological attack followed by the development of ischemic cholangiopathy. Further studies on the unique anatomy of the bile ducts supplied by PVP, both expressing graft-specific antigens, are essential for evaluation of and therapeutical approach to ischemic cholangiopathies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AS:
-
Anastomotic biliary stricture
- BCS:
-
Biliary cast syndrome
- BDN:
-
Bile duct necrosis
- BECs:
-
Biliary epithelial cells
- DSA:
-
Donor-specific antibodies
- HR:
-
Hypoxia/reperfusion
- IA:
-
Isoagglutinin
- ITBL:
-
Ischemic-type biliary stricture
- LPS:
-
Lipopolysaccharides
- LT:
-
Liver transplantation
- NAS:
-
Nonanastomotic biliary strictures
- PAMPs:
-
Pathogen-associated molecular patterns
- PCP:
-
Peribiliary capillary plexus
- PRR:
-
Pathogen recognition receptors
- PVP:
-
Peribiliary vascular plexus
- ROS:
-
Reactive oxygen species
- TACE:
-
Transarterial chemoembolization
- TLRs:
-
Toll-like receptors
References
Demetris AJ, Bellamy CO, Gandhi CR, Prost S, Nakanuma Y, Stolz DB. Functional immune anatomy of the liver – as an allograft. Am J Transplant. 2016;16(6):1653–80.
Nakanuma Y, Hoso M, Sanzen T, Sasaki M. Microstructure and development of the normal and pathologic biliary tract in humans, including blood supply. Microsc Res Tech. 1997;38(6):552–70.
Kobayashi S, Nakanuma Y, Matsui O. Intrahepatic peribiliary vascular plexus in various hepatobiliary diseases: a histological survey. Hum Pathol. 1994;25(9):940–6.
Kienlein S, Schoening W, Andert A, Kroy D, Neumann UP, Schmeding M. Biliary complications in liver transplantation: Impact of anastomotic technique and ischemic time on short- and long-term outcome. World J Transplant. 2015;5(4):300–9.
Kobayashi S, Nakanuma Y, Terada T, Matsui O. Postmortem survey of bile duct necrosis and biloma in hepatocellular carcinoma after transcatheter arterial chemoembolization therapy: relevance to microvascular damages of peribiliary capillary plexus. Am J Gastroenterol. 1993;88(9):1410–5.
Sun Z, Li G, Ai X, et al. Hepatic and biliary damage after transarterial chemoembolization for malignant hepatic tumors: incidence, diagnosis, treatment, outcome and mechanism. Crit Rev Oncol Hematol. 2011;79(2):164–74.
Hansen T, Hollemann D, Pitton MB, et al. Histological examination and evaluation of donor bile ducts received during orthotopic liver transplantation--a morphological clue to ischemic-type biliary lesion? Virchows Arch. 2012;461(1):41–8.
op den Dries S, Westerkamp AC, Karimian N, et al. Injury to peribiliary glands and vascular plexus before liver transplantation predicts formation of non-anastomotic biliary strictures. J Hepatol. 2014;60(6):1172–9117.
Kono N, Nakanuma Y. Ultrastructural and immunohistochemical studies of the intrahepatic peribiliary capillary plexus in normal livers and extrahepatic biliary obstruction in human beings. Hepatology. 1992;15(3):411–8.
Lazaridis KN, LaRusso NF. The cholangiopathies. Mayo Clin Proc. 2015;90(6):791–800.
Celli A, Que FG, Gores GJ, et al. Glutathione depletion is associated with decreased Bcl-2 expression and increased apoptosis in cholangiocytes. Am J Phys. 1998;275(4Pt1):G749–57.
Dechêne A, Kodde C, Kathemann S, et al. Endoscopic treatment of pediatric post-transplant biliary complications is safe and effective. Dig Endosc. 2015;27(4):505–11.
Feng L, Pang L, Guo Y, et al. Hypoxia/reoxygenation up-regulates death receptor expression and enhances apoptosis in human biliary epithelial cells. Life Sci. 2009;85(9–10):401–7.
Beuers U, Hohenester S, de Buy Wenniger LJ, Kremer AE, Jansen PL, Elferink RP. The biliary HCO(3)(-) umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies. Hepatology. 2010;52(4):1489–96.
Nakanuma Y, Sasaki M, Harada K. Autophagy and senescence in fibrosing cholangiopathies. J Hepatol. 2015;62(4):934–45.
Land WG. Innate immunity-mediated allograft rejection and strategies to prevent it. Transplant Proc. 2007;39(3):667–72.
Jin S, Shi XJ, Sun XD, Wang SY, Wang GY. Sclerosing cholangitis secondary to bleomycin-iodinated embolization for liver hemangioma. World J Gastroenterol. 2014;20(46):17680–5.
Zhu XD, Shen ZY, Chen XG, Zang Y. Pathotyping and clinical manifestations of biliary cast syndrome in patients after an orthotopic liver transplant. Exp Clin Transplant. 2013;11(2):142–9.
Song GW, Lee SG, Hwang S, et al. Biliary stricture is the only concern in ABO-incompatible adult living donor liver transplantation in the rituximab era. J Hepatol. 2014;61(3):575–82.
Kaneku H, O’Leary JG, Banuelos N, et al. De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients. Am J Transplant. 2013;13(6):1541–8.
Iacob S, Cicinnati VR, Dechêne A, et al. Genetic, immunological and clinical risk factors for biliary strictures following liver transplantation. Liver Int. 2012;32(8):1253–61.
Cardinale V, Wang Y, Carpino G, et al. The biliary tree – a reservoir of multipotent stem cells. Nat Rev Gastroenterol Hepatol. 2012;9(4):231–40.
Kulaksiz H, Heuberger D, Engler S, Stielhl A. Poor outcome in progressive sclerosing cholangitis after septic shock. Endoscopy. 2008;40(3):214–8.
Disclosures
None
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Nakanuma, Y., Miyata, N. (2017). Vascular Supply of the Bile Duct and Ischemic Cholangiopathy. In: Nakanuma, Y. (eds) Pathology of the Bile Duct. Springer, Singapore. https://doi.org/10.1007/978-981-10-3500-5_5
Download citation
DOI: https://doi.org/10.1007/978-981-10-3500-5_5
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-3499-2
Online ISBN: 978-981-10-3500-5
eBook Packages: MedicineMedicine (R0)